Eurizon Capital SGR S.p.A. purchased a new stake in Agilent Technologies, Inc. (NYSE:A – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 144,223 shares of the medical research company’s stock, valued at approximately $19,630,000.
Several other large investors have also added to or reduced their stakes in the business. Massachusetts Financial Services Co. MA lifted its position in Agilent Technologies by 13.8% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock valued at $1,925,064,000 after acquiring an additional 1,713,216 shares in the last quarter. Wellington Management Group LLP lifted its position in Agilent Technologies by 4.8% in the 3rd quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock valued at $1,203,990,000 after acquiring an additional 433,342 shares in the last quarter. Geode Capital Management LLC grew its holdings in Agilent Technologies by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock worth $1,006,519,000 after buying an additional 25,139 shares in the last quarter. Generation Investment Management LLP grew its holdings in Agilent Technologies by 10.1% during the third quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock worth $816,043,000 after buying an additional 582,093 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its position in Agilent Technologies by 15.1% in the 3rd quarter. Ameriprise Financial Inc. now owns 2,708,591 shares of the medical research company’s stock valued at $347,685,000 after buying an additional 354,480 shares during the last quarter.
Analyst Ratings Changes
A number of equities research analysts recently commented on A shares. Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Saturday. Morgan Stanley lowered their price target on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. Barclays increased their price target on Agilent Technologies from $140.00 to $145.00 and gave the company an “overweight” rating in a research report on Thursday. TD Cowen increased their price target on Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research report on Thursday. Finally, Wells Fargo & Company lowered their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Thursday. Two research analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $162.79.
Agilent Technologies Trading Up 0.0%
NYSE:A opened at $135.38 on Friday. The company has a current ratio of 2.10, a quick ratio of 1.59 and a debt-to-equity ratio of 0.43. The stock has a market capitalization of $38.26 billion, a PE ratio of 27.19, a price-to-earnings-growth ratio of 2.84 and a beta of 1.22. The firm’s 50 day moving average is $115.93 and its 200 day moving average is $128.76. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $160.27.
Agilent Technologies (NYSE:A – Get Free Report) last posted its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company had revenue of $1.84 billion for the quarter, compared to analysts’ expectations of $1.80 billion. During the same quarter in the previous year, the firm posted $1.31 EPS. Agilent Technologies’s revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts expect that Agilent Technologies, Inc. will post 5.98 earnings per share for the current year.
Agilent Technologies Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be paid a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s payout ratio is currently 20.48%.
Agilent Technologies News Summary
Here are the key news stories impacting Agilent Technologies this week:
- Positive Sentiment: Agilent beat Q2 earnings and revenue estimates, with EPS of $1.49 and revenue of $1.84 billion, both ahead of expectations. Agilent Technologies (A) Tops Q2 Earnings and Revenue Estimates
- Positive Sentiment: The company raised fiscal 2026 guidance after the strong quarter, signaling management expects momentum to continue. Agilent Lifts Outlook After 2Q Profit, Rev Rise
- Positive Sentiment: Bank of America upgraded Agilent to Buy, while TD Cowen and Barclays also lifted price targets, reinforcing the improving analyst view on the stock. Agilent Technologies shares jump on earnings beat, Bank of America upgrade
- Positive Sentiment: Market commentary highlighted Agilent’s strong execution, market share gains, and broader demand improvement across key instrument categories. Agilent Technologies Stock Soars On Broad Q2 Beat, Company Stands Out In Tools Sector
- Neutral Sentiment: Some articles compared Agilent with peers or discussed broader market themes, which are less likely to directly affect the stock near term. Agilent Technologies (NYSE:A) vs. Lonza Group (OTCMKTS:LZAGY) Head-To-Head Comparison
- Neutral Sentiment: Agilent was also mentioned in “stocks to watch” and momentum-focused coverage, reflecting continued investor attention rather than a new fundamental catalyst. Agilent Technologies, Snowflake And 3 Stocks To Watch Heading Into Friday
About Agilent Technologies
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
See Also
- Five stocks we like better than Agilent Technologies
- Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
